Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far

Research output: Contribution to journalReviewpeer-review

DOI

  1. Women With Diabetes Are at Increased Relative Risk of Heart Failure Compared to Men: Insights From UK Biobank

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. BLTR1 and CD36 Expressing Microvesicles in Atherosclerotic Patients and Healthy Individuals

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. First-in-human results of the OMEGA™ Left Atrial Appendage Occluder for Patients with Non-Valvular Atrial Fibrillation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Impact of early hospital discharge on clinical outcomes after transcatheter aortic valve implantation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Contemporary management of severe symptomatic bicuspid aortic valve stenosis: the BiTri Registry

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Transcatheter aortic valve replacement (TAVR) is an established alternative to surgical valve replacement for patients with severe aortic stenosis (AS) and increased surgical risk. On the basis of the favorable outcomes of recent randomized clinical trials conducted in intermediate and low risk populations, TAVR is expected in the near future to be offered to patients not only at lower surgical risk, but also with longer life expectancy. In this particular subset, the long-term durability of the bioprosthetic valve is of critical importance. The European Association of Percutaneous Cardiovascular Interventions (EAPCI), the European Society of Cardiology (ESC), and the European Association for Cardio-Thoracic Surgery (EACTS) recently introduced standardized criteria to define structural valve deterioration (SVD) and valve failure of transcatheter and surgical aortic bioprosthesis-this with the aim to generate uniformity in data reporting in future studies assessing long-term durability of aortic bioprosthesis. On this background, the aim of this article is to review the definition, incidence and predictors of transcatheter bioprosthetic valve dysfunction, including structural and non-structural valve deterioration (SVD/NSVD), valve thrombosis, and endocarditis.

Original languageEnglish
JournalFrontiers in Cardiovascular Medicine
Volume6
Pages (from-to)145
ISSN2297-055X
DOIs
Publication statusPublished - 2019

ID: 59143716